Alps Advisors Inc Chemo Centryx, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$22.17 - $51.8 $72,141 - $168,557	-3,254 Reduced 7.7%	38,984 $2.01 Million
Q2 2022 Aug 11, 2022	SELL	$15.36 - $27.51 $469,463 - $840,815	-30,564 Reduced 41.98%	42,238 $1.05 Million
Q1 2022 May 16, 2022	SELL	$22.22 - $39.12 $183,048 - $322,270	-8,238 Reduced 10.17%	72,802 $1.83 Million
Q4 2021 Feb 09, 2022	SELL	$18.38 - $40.5 $85,246 - $187,839	-4,638 Reduced 5.41%	81,040 $2.95 Million
Q3 2021 Nov 15, 2021	SELL	$13.18 - $19.83 $81,531 - $122,668	-6,186 Reduced 6.73%	85,678 $1.47 Million
Q2 2021 Aug 11, 2021	SELL	$9.59 - $50.88 $326,808 - $1.73 Million	-34,078 Reduced 27.06%	91,864 $1.23 Million
Q1 2021 May 07, 2021	BUY	$49.53 - $68.4 $70,283 - $97,059	1,419 Added 1.14%	125,942 $6.45 Million
Q4 2020 Feb 03, 2021	BUY	$47.25 - $65.16 $1.73 Million - $2.39 Million	36,670 Added 41.74%	124,523 $7.71 Million
Q3 2020 Nov 04, 2020	BUY	$46.35 - $61.69 $160,973 - $214,249	3,473 Added 4.12%	87,853 $4.81 Million
Q2 2020 Aug 05, 2020	SELL	$38.58 - $65.07 $820,133 - $1.38 Million	-21,258 Reduced 20.12%	84,380 $4.86 Million
Q1 2020 May 06, 2020	SELL	$32.73 - $50.78 $381,304 - $591,587	-11,650 Reduced 9.93%	105,638 $4.25 Million
Q4 2019 Feb 07, 2020	BUY	$6.81 - $39.55 $8,028 - $46,629	1,179 Added 1.02%	117,288 $4.64 Million
Q3 2019 Nov 04, 2019	SELL	$6.47 - $8.96 $34,834 - $48,240	-5,384 Reduced 4.43%	116,109 $787,000
Q2 2019 Aug 07, 2019	SELL	$8.31 - $14.85 $4,537 - $8,108	-546 Reduced 0.45%	121,493 $1.13 Million
Q1 2019 May 01, 2019	SELL	$10.01 - $13.89 $345,545 - $479,482	-34,520 Reduced 22.05%	122,039 $1.7 Million
Q4 2018 Feb 04, 2019	BUY	$9.15 - $12.26 $234,514 - $314,223	25,630 Added 19.58%	156,559 $1.71 Million
Q3 2018 Oct 25, 2018	BUY	$10.49 - $13.72 $248,592 - $325,136	23,698 Added 22.1%	130,929 $1.66 Million
Q2 2018 Aug 02, 2018	BUY	$10.62 - $13.98 $1.14 Million - $1.5 Million	107,231 New	107,231 $1.41 Million
Q2 2018 Jul 25, 2018	SELL	$10.62 - $13.98 $399,216 - $525,522	-37,591 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$5.9 - $14.99 $221,786 - $563,489	37,591 New	37,591 $511,000

Others Institutions Holding CCXI

# of Institutions

Shares Held

66.3K

Call Options Held

Put Options Held

View Full List

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account